A meta-analysis of the relative efficacy and toxicity of Pneumocystis carinii prophylactic regimens

Archives of Internal Medicine

Volumn 156, Issue 2, 1996, Pages 177-188

  Ioannidis, John P A ^a   Cappelleri, Joseph C ^a   Skolnik, Paul R ^a   Lau, Joseph ^a   Sacks, Henry S ^b  

^a TUFTS MEDICAL CENTER   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; COTRIMOXAZOLE; DAPSONE; PENTAMIDINE;

AEROSOL; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG ERUPTION; DRUG INDUCED DISEASE; FEVER; HUMAN; INFECTION PREVENTION; INHALATIONAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; META ANALYSIS; MORTALITY; NEUTROPENIA; ORAL DRUG ADMINISTRATION; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TABLET; TOXOPLASMOSIS; TREATMENT OUTCOME;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; DAPSONE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LOGISTIC MODELS; MULTIVARIATE ANALYSIS; ODDS RATIO; PENTAMIDINE; PNEUMONIA, PNEUMOCYSTIS; RANDOMIZED CONTROLLED TRIALS; SURVIVAL ANALYSIS; TOXOPLASMOSIS; TREATMENT OUTCOME; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 0030041465     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.156.2.177     Document Type: Article

References (64)

1. Public Health Service Task Force on Antipneumocystis Prophylaxis in Patients With Human Immunodeficiency Virus Infection Recommendations for prophylaxis against Pneumocystis carinii pneumonia for persons infected with human immunodeficiency virus. J Acquir Immune Defic Syndr 1993,6:46-55.
2. Masur H. Prevention and treatment of Pneumocystis pneumonia N Engl J Med 1992,327.1853-1860
3. Gallant JE, Moore RD, Chaisson RE. Prophylaxis for opportunistic infections in patients with HIV infection. Ann Intern Med. 1994,120 932-944
4. 3: a cost-effectiveness analysis. J Acquir Immune Defic Syndr. 1991,4:521-531.
5. Blum RN, Miller LA, Gaggini LC Cohn DL Comparative trial of dapsone versus trimethoprim/sulfamethoxazole for primary prophylaxis of Pneumocystis carinii pneumonia J Acquir Immune Defic Syndr. 1992;5:341-347.
6. Jung AC, Paauw DS Management of adverse reactions to trimethoprim-sulfamethoxazole in human immunodeficiency virus-infected patients. Arch Intern Med. 1994,154:2402-2406.
7. Bozzette SA, Finkelstein DM, Spector SA, et al. A randomized trial of three antipneumocystis agents in patients with advanced immunodeficiency virus infection N Engl J Med. 1995;332:693-699.
8. Sacks H, Chalmers TC, Smith H. Randomized versus historical controls for clinical trials Am J Med 1982,72:233-240.
9. DerSimonian R, Laird MM. Meta-analysis in clinical trials Control Clin Trials. 1986;7:177-188
10. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719-748.
11. Ioannidis JPA, Cappelleri JC, Lau J, et al. Early or deferred zidovudine in HIV-infected patients without an AIDS-defining illness. Ann Intern Med 1995;122: 856-866.
12. Fleiss JL Statistical Methods for Rates and Proportions. New York. NY John Wiley & Sons Inc; 1981.
13. SAS Institute Inc. SAS Guide for Personal Computers Version 6.03 Cary, NC: SAS Institute Inc 1988.
14. Hosmer DW, Lemeshow S Applied Logistic Regression. New York, MY: John Wiley & Sons Inc, 1989.
15. Fischl MA, Dickinson GM, LaVoie L. Safety and efficacy of sulfamethoxazole and trimethoprim chemoprophylaxis for Pneumocystis carinii pneumonia in AIDS. JAMA. 1988;259:1185-1189.
16. Girard P-M, Landman R, Gaudebout C, et al. Prevention of Pneumocystis carinii pneumonia relapse by pentamidine aerosol in zidovudine-treated AIDS patients. Lancet. 1989,1 1348-1353
17. O'Doherty M, Thomas S, Page C, Bradbeer C, Nunan T, Bateman N. Pulmonary deposition of nebulized pentamidine isoethionate: effect of nebulizer type, dose, and volume of fill Thorax. 1990;45:460-464.
18. Howite JS, Baskin MI, Sheetz MS, Abd AG. Delivered dose and regional distribution of aerosolized pentamidine using different delivery systems. Chest. 1991:99:1139-1144
19. Diamond GA. Limited assurances Am J Cardiol. 1989;63:99-100.
20. Deim K, Lentner C, eds. Scientific Tables. 7th ed. Basel, Switzerland: CIBA-Geigy Ltd; 1970.
21. Antinori A, Fantoni M, Maiuro G, et al. Aerosolized pentamidine and oral dapsone in secondary prophylaxis of PCP in AIDS patients. In: Program and abstracts of the Seventh International Conference on AIDS; June 16-21, 1991; Florence, Italy. Abstract WB 2241.
22. Antinori A, Murri R, Tamburrini E, De Luca A, Ortona L. Failure of low-dose dapsone-pyrimethamme in primary prophylaxis of Pneumocystis carinii pneumonia Lancet. 1992;340:788.
23. Bozzette SA, Forthal D, Sattler FR, et al. The tolerance for zidovudine plus thrice weekly or daily trimethoprim-sulfamethoxazole with and without leucovorin for primary prophylaxis in advanced HIV disease. Am J Med. 1995; 98:177-182
24. Girard P-M, Landman R, Gaudebout C, et al. Dapsone-pyrimethamine compared with aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection. N Engl J Med. 1993,328:1514-1520.
25. Golden JA, Katz MH, Chernoff DN, Duncan SM, Conte JE. A randomized comparison of once-monthly or twice-monthly high dose aerosolized pentamidine prophylaxis. Chest 1993;104.743-750.
26. Grunewald T, Bergmann F, Eljaschewitsch J, Pohle HD, Ruf B. Antiprotozoal prophylaxis in AIDS patients: results of a prospective randomized study comparing dapsone/pyrimethamine and sulfadoxine/pyrimethamine. In. Program and abstracts of the Ninth International Conference on AIDS; June 6-11, 1993; Berlin, Germany. Abstract WS-B13-3
27. Hardy WD, Feinberg J Finkelstein DM, et al A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome N Engl J Med 1992,327.1842-1848
28. Hirschel B, Lazzarin A, Chopard P, et al. A controlled study of inhaled pentamidine for primary prevention of Pneumocystis carinii pneumonia. N Engl J Med 1991;324:1079-1083.
29. Jensen BN, Nielsen TL, Backer V, et al. Aerosolized pentamidine for primary prophylaxis of Pneumocystis carinii pneumonia: a controlled, randomized trial. J Acquir Immune Defic Syndr 1993,6:472-477.
30. Lavelle J, Falloon J, Morgan A, et al. Weekly dapsone and dapsone/ pyrimethamine for PCP prophylaxis. In: Program and abstracts of the Seventh International Conference on AIDS, June 16-21, 1991; Florence, Italy. Abstract WB 2207.
31. Leoung GS, Feigal DW, Montgomery B, et al. Aerosolized pentamidine for prophylaxis against Pneumocystis carinii pneumonia. N Engl J Med. 1990;323: 769-775.
32. Lidman C, Berglund O, Tynell E, Lindbäck S, Elvin K. Aerosolized pentamidine as primary prophylaxis for Pneumocystis carinii pneumonia: efficacy, mortality and morbidity. AIDS, 1994;8:935-939.
33. Mallolas J, Zamora L, Gatell JM, et al Primary prophylaxis for Pneumocystis carinii pneumonia: a randomized trial comparing cotrimoxazole, aerosolized pentamidine and dapsone plus pyrimethamine. AIDS. 1993;7:59-64
34. May T, Beuscart C, Reynes J, et al. Trimethoprim-sulfamethoxazole versus aerosolized pentamidine for primary prophylaxis of Pneumocystis carinii pneumonia: a prospective, randomized, controlled clinical trial. J Acquir Immune Defic Syndr 1994,7.457-462
35. Michelet C, Raffi F, Besnier JM, et al. Cotrimoxazole versus aerosolized pentamidine for primary prophylaxis of Pneumocystis carinii pneumonia (PCP). In: Program and abstracts of the Eighth International Conference on AIDS; July 19-24, 1992; Amsterdam, the Netherlands. Abstract PoB 3312.
36. Montaner JSG, Lawson LM, Gervais A, et al. Aerosol pentamidine for secondary prophylaxis of AIDS-related Pneumocystis carinii pneumonia. Ann Intern Med. 1991;114:948-953.
37. Murphy RL, Lavelle JP, Allan JD, et al. Aerosol pentamidine prophylaxis following Pneumocystis carinii pneumonia in AIDS patients: results of a blinded dose-comparison study using an ultrasonic nebulizer. Am J Med. 1991;90: 418-426.
38. Nielsen TL, Jensen BN, Mathiesen GJ, Gorstoft J, Skinhoj P, Nielsen JO. Secondary Pneumocystis prophylaxis: a prospective study with low-dose sulfamethoxazole-trimethoprim vs low-dose aerosolized pentamidine. In: Program and abstracts of the Seventh International Conference on AIDS; June 16-21, 1991; Florence, Italy. Abstract WB 2224.
39. Opravil M, Hirschel B, Lazzarin A, et al. Once-weekly administration of dapsone/ pyrimethamine vs aerosolized pentamidine as combined prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus-infected patients. Clin Infect Dis. 1995;20:531-541
40. Perez G, Marton R, Sihoi L, et al A randomized, prospective comparison of twice daily and thrice weekly trimethoprim-sulfamethoxazole as Pneumocystis prophylaxis. In. Program and abstracts of the Seventh International Conference on AIDS; June 16-21, 1991; Florence, Italy. Abstract WB 2199
41. Podzamczer D, Santin M, Jimenez J, Casanova A, Bolao F, Gudiol GRF. Thrice-weekly cotrimoxazole is better than weekly dapsone-pyrimethamine for the primary prevention of Pneumocystis carinii pneumonia in HIV-infected patients. AIDS. 1993,7:501-506.
42. Rizzardi GP, Frigerio D, Lazzarin A, Maillard M, Musicco M, Moroni M, for the Italian PCP PR Study Group. Prospective study of primary prophylaxis for PCP: a 1-year randomized trial comparing aerosolized pentamidine vs daily cotrimoxazole In: Program and abstracts of the Ninth International Conference on AIDS; June 6-11, 1993; Berlin, Germany. Abstract PO-B10-1519.
43. Rizzardi GP, Lazzarin A, Frigerio D, et al Two dosages of inhaled pentamidine for secondary prophylaxis of PCP: a 1-year randomized controlled trial. In: Program and abstracts of the Tenth International Conference on AIDS; August 1994; Yokohama, Japan. Abstract PB0612.
44. Rozenbaum W, Tavares M, Navarette MS, Gharakhanian S, Cardon B, Lebrette HG. Evaluation of trimethoprim sulfamethoxazole vs aerosolized pentamidine with concomitant onset of zidovudine in primary Pneumocystis carinii pneumonia prophylaxis. In. Program and abstracts of the Seventh International Conference on AIDS; June 16-21, 1991; Florence, Italy. Abstract WB 2247.
45. Schneider MME, Hoepelman AIM, Schattenkerk JKME, et al. A controlled trial of aerosolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection N Engl J Med. 1992,327:1836-1841.
46. Sirera G, Clotet B, Romeu J, Raventos A, Gomez M, Paredes R. A randomized study of primary prophylaxis of Pneumocystis carinii pneumonia and cerebral toxoplasmosis with twice weekly dapsone-pyrimethamine versus thrice weekly cotrimoxazole. In Program and abstracts of the Second National Conference on Human Retroviruses; January 29-February 2, 1995; Washington, DC Abstract 295.
47. Slavin MA, Hoy JF, Stewart K, Pettinger MB, Lucas CR, Kent SJ. Oral dapsone versus nebulized pentamidine for Pneumocystis carinii prophylaxis: an open randomized prospective trial to assess efficacy and hematological toxicity. AIDS. 1992;6:1169-1174.
48. Smith DE, Hills DA, Gazzard BG. Patient tolerance of nebulized pentamidine or cotrimoxazole as secondary prophylaxis for Pneumocystis carinii pneumonia. AIDS. 1992;6:1044-1045
49. Stellini R, Castelnuovo F, Paraninfo G, Scalzini A. Trimethoprim-sulfamethoxazole versus pyrimethamine in the primary prophylaxis of toxoplasmic encephalitis in HIV positive patients: preliminary results of a randomized prospective study. In. Program and abstracts of the Ninth International Conference on AIDS; June 6-11, 1993, Berlin, Germany. Abstract PO-B10-1505
50. Tocchetti A, Tambini R, Allegro A, Longoni E, Rinaldi E. Four different regimens for prevention of Pneumocystis carinii pneumonia and Toxoplasma encephalitis in HIV-infected patients AIDS. 1994;8:212-214.
51. Torres RA, Barr M, Thorn M, et al. Randomized trial of dapsone and aerosolized pentamidine for the prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis Am J Med. 1993;95:573-583.
52. Colebunders R, Izaley L, Bila K. Cutaneous reactions to trimethoprim-sulfamethoxazole in African patients with the acquired immunodeficiency syndrome. Ann Intern Med. 1987;107:599-600.
53. Jacobson LP, Kirby AJ, Polk S, et al. Changes in survival after acquired immunodeficiency syndrome (AIDS). 1984-1991. Am J Epidemiol. 1993;138: 952-964.
54. Absar N, Daneshvar H, Beall G. Desensitization to trimethoprim/ sulfamethoxazole in HIV-infected patients. J Allergy Clin Immunol. 1994;93: 1001-1005
55. Gluckstein D, Ruskin J. Rapid oral desensitization to trimethoprim-sulfamethoxazole (TMP-SMZ): use for prophylaxis for Pneumocystis carinii pneumonia in patients with AIDS who were previously intolerant to TMP-SMZ. Clin Infect Dis. 1995;20:849-853.
56. Kletzel M, Beck S, Elser J, Shock M, Burks W. Trimethoprim-sulfamethoxazole oral desensitization in hemophiliacs infected with human immunodeficiency virus with a history of hypersensitivity reactions. AJDC. 1991;145:1428-1429
57. Saah AJ, Hoover DR, Peng Y, et al, for the Multicenter AIDS Cohort Study. Predictors for failure of Pneumocystis carinii pneumonia prophylaxis. JAMA. 1995;273 1197-1202
58. Jacobson MA, Besch CL, Child C, et al. Primary prophylaxis with pyrimethamine for toxoplasmic encephalitis in patients with advanced human immunodeficiency virus disease: results of a randomized trial. J Infect Dis. 1994; 169:384-394.
59. Lidman C, Tynell E, Berglund O, Lindbaek S. Aerosolized pentamidine versus i.v. pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia. Infection. 1993,21:146-149.
60. Cheung TW, Matta R, Neibart E, et al. Intramuscular pentamidine for the prevention of Pneumocystis carinii pneumonia in patients infected with human immunodeficiency virus. Clin Infect Dis 1993;16 22-25.
61. Schneider MME, Nielsen TL, Nelsing S, et al. Efficacy and toxicity of two doses of trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii penumonia in patients with human immunodeficiency virus. J Infect Dis. 1995,171:1632-1636.
62. Podzamczer D, Salazar A, Jimenez J, et al. Intermittent trimethoprim-sulfamethoxazole compared with dapsone-pyrimethamine for the simultaneous primary prophylaxis of Pneumocystis pneumonia and toxoplasmosis in patients infected with HIV Ann Intern Med. 1995,122.755-761.
63. Zamora L, Mallolas J, Miro JM, et al Primary prophylaxis of toxoplasmic encephalitis and P. carinii pneumonia in HIV patients. In: Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy: September 17-20, 1995; San Francisco, Calif.
64. Salmon-Ceron D, Fontbonne A, Saba J, et al. Lower survival in AIDS patients receiving dapsone compared with aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia J Infect Dis. 1995;172.656-664.